Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

Sponsor
Human Genome Sciences Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00411385
Collaborator
Novartis (Industry)
933
159
3
20
5.9
0.3

Study Details

Study Description

Brief Summary

This is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of albumin interferon alfa-2b (alb-IFN)in combination with ribavirin compared with peginterferon alfa-2a (PEGASYS or PEG-IFNa2a) in combination with ribavirin in subjects with chronic hepatitis C, genotype 2/3 who are IFNa treatment naive.

Condition or Disease Intervention/Treatment Phase
  • Drug: albumin interferon alfa-2b
  • Drug: peginterferon alfa-2a
  • Drug: Ribavirin
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
933 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Phase3 Study to Evaluate the Efficacy and Safety of AlbuminInterferon in Combination With Ribavirin Compared With Peginterferon in Combination With Ribavirin in Interferon Alfa Naive Subjects With CHC Genotype 2/3.
Study Start Date :
Feb 1, 2007
Actual Primary Completion Date :
Oct 1, 2008
Actual Study Completion Date :
Oct 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

900 mcg alb-IFN every 2 weeks (12 doses) + Ribavirin 800 micrograms per day

Drug: albumin interferon alfa-2b
900 and 1200 micrograms Albumin Interferon Alpha 2a given subcutaneously once every two weeks for 24 weeks

Drug: Ribavirin
800mg/day for 24 weeks

Experimental: 2

1200 mcg alb-IFN every 2 weeks (12 doses) + Ribavirin 800 micrograms per day

Drug: albumin interferon alfa-2b
900 and 1200 micrograms Albumin Interferon Alpha 2a given subcutaneously once every two weeks for 24 weeks

Drug: Ribavirin
800mg/day for 24 weeks

Active Comparator: 3

180 mcg PEG-IFNx2a every 1 week (24 doses)+ Ribavirin 800 micrograms per day

Drug: peginterferon alfa-2a
180 micrograms Pegasys given subcutaneaously once a week for 24 weeks

Drug: Ribavirin
800mg/day for 24 weeks

Outcome Measures

Primary Outcome Measures

  1. Sustained virologic response (SVR) [Week 48]

Secondary Outcome Measures

  1. Rapid virologic response [Week 4]

  2. Early virologic response [Week 12]

  3. Undetectable HCV RNA [Week 24]

  4. Normalization of ALT (a liver enzyme) [Week 48]

  5. Quality of life evaluation [Week 48]

  6. Safety assessments (physical exams, Ae reporting, lab testing/analysis, HADS and Immunogenicity results) [Througout the entire treatment period]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Key Inclusion Criteria:
  • Diagnosis of chronic hepatitis C.

  • Liver biopsy performed within 2 years of Day 0 or during screening.

  • Infected with hepatitis C virus genotype 2/3.

  • Interferon alfa treatment naïve (ie, have never been treated with an interferon product).

  • Subjects are eligible to enter the study if they (or their partners) are not pregnant or nursing, are sterile, or of non childbearing potential, or are willing to practice abstinence or use appropriate birth control methods during the study and for 7 months after the last dose of ribavirin.

  • Have compensated liver disease.

Key Exclusion Criteria:
  • Decompensated liver disease including those subjects with a past history or presence of ascites, bleeding varices or hepatic encephalopathy.

  • History of moderate, severe or uncontrolled psychiatric disease, especially depression, including a history of hospitalization or prior suicidal attempt.

  • Positive for human immunodeficiency virus (HIV-1) or hepatitis B surface antigen (HBsAG).

  • Clinical diagnosis of other causes of chronic liver disease including but not limited to hepatitis B, autoimmune hepatitis, primary biliary cirrhosis, alcoholic liver disease, hemochromatosis, Wilson's Disease, or alpha 1-antitrypsin deficiency.

  • A history of immunologically mediated disease (eg, rheumatoid arthritis, inflammatory bowel disease, moderate/severe psoriasis, sarcoidosis, systemic lupus erythematosus).

  • Active seizure disorder within the last 2 years.

  • Organ transplant other than cornea and hair transplant.

  • Clinically significant hemoglobinopathy (eg, thalassemia, sickle cell anemia).

  • Cancer within the last 5 years(with the exception of adequately treated basal cell carcinoma of the skin or in situ carcinoma of the uterine cervix).

  • Drug or alcohol addiction within the last 6 months. Subjects in a supervised methadone treatment program may be enrolled in the study.

  • Received any experimental agent within 28 days prior to Day 0.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Hospital Phoenix Arizona United States 85054
2 Scripps Clinic La Jolla California United States 92037
3 California Pacific Medical Center San Francisco California United States 94115
4 University of Colorado Denver Colorado United States 80262-0001
5 University of Florida-Gainesville Gainesville Florida United States 32610
6 Shands Jacksonville Medical Center Jacksonville Florida United States 32209
7 Mayo Clinic Transplant Center Jacksonville Florida United States 32216
8 University of Miami Miami Florida United States 33136-1051
9 Atlanta Gastroenterology Associates Atlanta Georgia United States 30308
10 GI of Atlanta Atlanta Georgia United States 30309
11 University of Chicago Hospital Chicago Illinois United States 60637
12 Johns Hopkins Center for Viral Hepatits Baltimore Maryland United States 21287
13 Beth Israel Deaconess Medical Center Boston Massachusetts United States 02215
14 Minnesota Gastroenterology, P.A. Plymouth Minnesota United States 55446
15 Dartmouth Hitchcock Medical Center Lebanon New Hampshire United States 03756
16 University of New Mexico Albuquerque New Mexico United States 87131-0001
17 Bronx VA Medical Center Bronx New York United States 10468
18 New York Hospital - Cornell New York New York United States 10021
19 Faculty Practice Associates New York New York United States 10029
20 NY Presbyterian Medical Center - Columbia Univ. Med Center New York New York United States 10032
21 University of North Carolina at Chapel Hill Chapel Hill North Carolina United States 27599-7584
22 Regional Gastroenterology Associates of Lancaster, Ltd. Lancaster Pennsylvania United States 17604-3200
23 Thomas Jefferson University Philadelphia Pennsylvania United States 19107
24 Temple University Hospital Philadelphia Pennsylvania United States 19140
25 Baylor University Medical Center Dallas Texas United States 75246
26 Brooke Army Medical Center Fort Sam Houston Texas United States 78234
27 Alamo Medrical Research San Antonio Texas United States 78215
28 Metropolitan Research Fairfax Virginia United States 22031
29 Unidad de Hepatología Capital Federal Buenos Aires Argentina C1093AAS
30 Fundación Cidea Capital Federal Buenos Aires Argentina C1121ABE
31 Hospital Italiano Capital Federal Buenos Aires Argentina C1181ACH
32 Hospital Universitario Austral Pilar Buenos Aires Argentina B1629AHJ
33 Htal Pcial del Centenario Rosario Santa Fe Argentina 2000
34 Royal Prince Alfred Hospital Camperdown New South Wales Australia 2050
35 Concord Repatriation General Hospital Concord New South Wales Australia 2139
36 St George Hospital Clinical School of Medicine Kogarah New South Wales Australia 2217
37 John Hunter Hospital New Lambton New South Wales Australia 2305
38 Westmead Hospital Westmead New South Wales Australia 2145
39 Gallipoli Research Foundation and Greenslopes Private Hospital Greenslopes Queensland Australia 4120
40 Royal Bribane & Women's Hospital Herston Queensland Australia 4029
41 Royal Adelaide Hospital Adelaide South Australia Australia 5000
42 Monash Medical Centre Clayton Victoria Australia 3168
43 St Vincent's Hospital Fitzroy, Victoria Victoria Australia 3065
44 Western Hospital Footscray Victoria Australia 3011
45 Austin Hospital Heidelburg Victoria Australia 3081
46 The Alfred Hospital Melbourne Victoria Australia 3004
47 Royal Melbourne Hospital Parkville Victoria Australia 3050
48 Fremantle Hospital Fremantle Western Australia Australia 6160
49 CHU Brugmann ULB - site Victor Horta Brussels Belgium 1020
50 UCL Brussels Belgium 1200
51 University Hospital Antwerp Edegem Belgium 2650
52 Ghent University Hospital Gent Belgium 9000
53 CHU Sart Tilman Liège Belgium 4000
54 Hospital Universitário Professor Edgard Santos - Universidade Federal da Bahia Salvador BA Brazil 40110-170
55 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Ribeirão Preto SP Brazil 14049-900
56 Universidade Federal de São Paulo - UNIFESP São Paulo SP Brazil 04023-900
57 Hospital Heliópolis São Paulo SP Brazil 04230-000
58 Hospital das Clínicas da Faculdade de Medicina da USP São Paulo SP Brazil 05403-000
59 Heritage Medical Research Clinic Calgary Alberta Canada T2N 4N1
60 University of Alberta Edmonton Alberta Canada T5H 4B9
61 University of Alberta Hospital Edmonton Alberta Canada T6G 2X8
62 Vancouver General Hospital Vancouver British Columbia Canada V5Z 3P1
63 University of Manitoba Health Sciences Centre Winnipeg Manitoba Canada R3E 3P4
64 University of Western Ontario Hospital London Ontario Canada N6A 5A5
65 Ottawa Hospital - General Campus Ottawa Ontario Canada K1H 8L6
66 Toronto General Hospital Toronto Ontario Canada M5G 2N2
67 Toronto Western Hospital Toronto Ontario Canada M5T 2S8
68 McGill University Montreal Quebec Canada H3A 1A1
69 Hopital Beaujon Clichy France 92110
70 Hopital Henri Mondor Creteil France 94010
71 CHU de Lyon, Hôpital de l'Hôtel Dieu Lyon Cedex 02 France 69288
72 Hopital Saint-Joseph Marseille Cedex 08 France 13285
73 Hopital de La Source Orleans France 45100
74 Hôpital Saint-Antoine Paris France 75012
75 Hopital Pitie-Salpetriere Paris France 75013
76 Hopital Haut-Leveque Pessac cedex France 33600
77 CHU Purpan Clinique Dieulafoy Toulouse Cedex France 31059
78 Hôpital de Brabois Vandoeuvre France 54511
79 UH Charite Berlin / Virchow Klinikum Berlin Germany 13353
80 Universitätsklinik Düsseldorf Duesseldorf Germany 40255
81 Center for HIV and Hepatogastroenterology Düsseldorf Germany 40237
82 UH Essen Essen Germany 45122
83 Klinikum der Johann Wolfgang Goethe-Universitaet Frankfurt / Main Germany 60590
84 Albert-Ludwigs-Universitaet Freiburg Freiburg Germany 79106
85 Medizinische Hochschule Hannover (MHH) Hannover Germany 30623
86 Universitätsklinikum Heidelberg Heidelberg Germany 69120
87 Universitätsklinikum Leipzig Leipzig Germany 4103
88 Johannes Gutenberg-Universitaet Mainz Mainz Germany 55101
89 Paracelsus Klinik der Stadt Marl Marl Germany 45770
90 Dayanand Medical College and Hospital Ludhiana India 141001
91 Jaslok Hospital and Research Centre and Breach Candy Hospital, Mumbai India 400 0026
92 P. D. Hinduja National Hospital and Medical Research Centre Mumbai India 400 016
93 G.B.Pant Hospital New Delhi India 110 002
94 Maulana Azad Medical College and Associated Lok Nayak Hospital New Delhi India 110 002
95 Bnei-Zion Medical Center Haifa Israel 31048
96 Rambam Health Care Campus Haifa Israel 31096
97 Hadassah Medical Organization Jerusalem Israel 91120
98 Holy Family Hospital Nazareth Israel 16100
99 Rabin Medical Center Beilinson Campus Petach Tikva Israel 49100
100 Tel Aviv Sourasky Medical Center Tel Aviv Israel 64239
101 Bundang CHA Hospital Bundang Korea, Republic of 463-712
102 Kyungpook National University Hospital Daegu Korea, Republic of 700-721
103 Pusan National University Hospital Pusan Korea, Republic of 602-739
104 Seoul National University Hospital(Bundang) Seonnam City Korea, Republic of 463-802
105 Severance Hospital(SVR) Seoul Korea, Republic of 120-752
106 Kyunghee University - Medical center Seoul Korea, Republic of 130-702
107 Samsung Medical Center Seoul Korea, Republic of 135-710
108 Yongdong Severance Hospital Seoul Korea, Republic of 135-720
109 Korea University Medical Center(Anam) Seoul Korea, Republic of 136-705
110 Asan Medical Center Seoul Korea, Republic of 138-736
111 Korea University Medical Center(Guro) Seoul Korea, Republic of 152-703
112 Aju University Hospital Suwon Korea, Republic of 443-821
113 Hospital Alor Setar Alor Setar Malaysia 5150
114 Hospital Kuala Lumpur Kuala Lumpur Malaysia 50586
115 University Malaya Medical Centre Kuala Lumpur Malaysia 50603
116 HUKM Kuala Lumpur Malaysia 56000
117 Hospital Selayang Selangor Malaysia 68100
118 Hosp. Universitario. Monterrey Monterrey N.L. CP Mexico 64460
119 Instituto Nac. de Cs Médicas y Nutrición "Salvador Zubirán" Mexico DF Mexico 14000
120 Clínica Lomas Altas Mexico City Mexico 11950
121 Wojewódzki Szpital Specjalistyczny Bialystok Poland 15-540
122 Niepubliczny Zaklad Opieki Zdrowotnej Czeladz Poland 41-250
123 Wojewódzki Szpital Zespolony Kielce Poland 25-317
124 Szpital Uniwersytecki w Krakowie Krakow Poland 31-531
125 Uniwersytet Medyczny Lodz Poland 91-347
126 Wojewódzki Szpital Zakaźny Warszawa Poland 01-201
127 Przychodnia przy Łowieckie Wroclaw Poland 50-220
128 Fundacion de Investigacion de Diego Santurce Puerto Rico 909
129 National University Hospital Singapore Singapore 119074
130 Singapore General Hospital Singapore Singapore 169608
131 Tan Tock Seng Hospital Singapore Singapore 308433
132 CGH Singapore Singapore 529889
133 Hospital Universitari Germans Trias i Pujol Badalona - Barcelona Spain 8916
134 Hopital Universitari Vall d'Hebron Barcelona Spain 8035
135 Hospital Clinic i Provincial Barcelona Spain 8036
136 Hospital Universitario La Princesa Madrid Spain 28006
137 Hospital General Universitario Gregorio Marañón Madrid Spain 28007
138 Hospital Carlos III Madrid Spain 28029
139 Complejo Hospitalario Nuestra Señora de Valme Sevilla Spain 41014
140 Consorcio Hospital General Universitario de Valencia Valencia Spain 46014
141 Universitetssjukhuset MAS Malmö Sweden 205 02
142 Karolinska Universitetssjukhuset Stockholm Sweden 171 76
143 TCGH-HL Hualien R.o.c. Taiwan 970
144 KMUH Kaohsiung R.o.c. Taiwan 807
145 KCGMH Kaohsiung R.o.c. Taiwan 833
146 VGH-TC Taichung R.o.c. Taiwan 407
147 NTUH Taipei R.o.c. Taiwan 100
148 TSGH Taipei R.o.c. Taiwan 114
149 CGMH-LK Taoyuan R.o.c. Taiwan 333
150 CCH Changhua Taiwan 500
151 CMUH Taichung Taiwan 404
152 NCKUH Tainan Taiwan 704
153 CMMC Tainan Taiwan 710
154 TCGH-TP Taipei Taiwan 231
155 Chulalongkorn Hospital Bangkok Thailand 10330
156 Ramathibodi Hospital Bangkok Thailand 10400
157 Siriraj Hospital Bangkok Thailand 10700
158 Maharaj Nakorn Chiang Mai Hospital, Chiang Mai University Chiang Mai Thailand 50200
159 Barts and the London NHS Trust London United Kingdom E1 2AT

Sponsors and Collaborators

  • Human Genome Sciences Inc.
  • Novartis

Investigators

  • Study Director: GSK Clinical Trials, GlaxoSmithKline

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Human Genome Sciences Inc.
ClinicalTrials.gov Identifier:
NCT00411385
Other Study ID Numbers:
  • HGS1008-C1067
  • ACHIEVE-2/3
First Posted:
Dec 14, 2006
Last Update Posted:
Aug 8, 2013
Last Verified:
Aug 1, 2013

Study Results

No Results Posted as of Aug 8, 2013